Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cost Of Revenue | 31,608 | 27,368 | 31,701 | 35,100 | 32,069 | -- |
| Gross Profit | -31,608 | -27,368 | -31,701 | -35,100 | -32,069 | -- |
| Selling General And Administration | 252,100 | 304,395 | 276,486 | 279,312 | 268,936 | -- |
| General And Administrative Expense | 252,100 | 304,395 | 276,486 | 279,312 | 268,936 | -- |
| Other Operating Expenses | 462,020 | 381,786 | 386,441 | 140,230 | 242,660 | -- |
| Operating Expense | 714,120 | 686,181 | 662,927 | 419,542 | 511,596 | -- |
| Operating Income | -745,728 | -713,549 | -694,628 | -454,642 | -543,665 | -- |
| EBIT | -745,728 | -713,549 | -694,628 | -454,642 | -543,665 | -- |
| Interest Income | 0.00 | 120,497 | 2,716 | -- | 9,604 | 127,123 |
| Interest Income Non Operating | 0.00 | 120,497 | 2,716 | -- | 9,604 | 127,123 |
| Net Interest Income | 0.00 | 120,497 | 2,716 | -- | 9,604 | 127,123 |
| Other Income Expense | 333,376 | 52,675 | 692,363 | 48,325 | 177,288 | -- |
| Other Non Operating Income Expenses | 246,566 | -- | 737,676 | 102,477 | 115,272 | 113,044 |
| Special Income Charges | 62.00 | 4,010 | -- | -- | -- | -- |
| Gain On Sale Of Security | 86,748 | 48,665 | -45,313 | -54,152 | 62,016 | -- |
| Pretax Income | -412,352 | -540,377 | 451.00 | -446,102 | -356,773 | -- |
| Tax Provision | 0.00 | 0.00 | 0.00 | -53,064 | 0.00 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | -6,441 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -412,352 | -540,377 | 451.00 | -393,038 | -356,773 | -- |
| Net Income From Continuing Operation Net Minority Interest | -412,352 | -540,377 | 451.00 | -393,038 | -356,773 | -- |
| Net Income Including Noncontrolling Interests | -412,352 | -540,377 | 451.00 | -393,038 | -356,773 | -- |
| Net Income Common Stockholders | -412,352 | -540,377 | 451.00 | -393,038 | -356,773 | -- |
| Net Income | -412,352 | -540,377 | 451.00 | -393,038 | -356,773 | -- |
| EBITDA | -714,120 | -686,181 | -662,927 | -419,542 | -511,596 | -- |
| Normalized EBITDA | -800,930 | -738,856 | -617,614 | -365,390 | -573,612 | -- |
| Reconciled Depreciation | 31,608 | 27,368 | 31,701 | 35,100 | 32,069 | -- |
| Basic EPS | 0.00 | -0.01 | 0.01 | -- | 0.00 | -0.01 |
| Diluted EPS | 0.00 | -0.01 | 0.01 | -- | 0.00 | -0.01 |
| Basic Average Shares | 105.6M | 105.1M | 105.1M | -- | 105.1M | 104.5M |
| Diluted Average Shares | 105.6M | 105.1M | 105.1M | -- | 105.1M | 104.5M |
| Total Unusual Items | 86,810 | 52,675 | -45,313 | -54,152 | 62,016 | -- |
| Total Unusual Items Excluding Goodwill | 86,810 | 52,675 | -45,313 | -54,152 | 62,016 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | -- |
| Normalized Income | -499,162 | -593,052 | 45,764 | -345,327 | -418,789 | -- |
| Diluted NI Availto Com Stockholders | -412,352 | -540,377 | 451.00 | -393,038 | -356,773 | -- |
| Gain On Sale Of Ppe | 62.00 | 4,010 | -- | -- | -- | -- |
| Net Income Continuous Operations | -412,352 | -540,377 | 451.00 | -393,038 | -356,773 | -- |
| Net Non Operating Interest Income Expense | 0.00 | 120,497 | 2,716 | -- | 9,604 | 127,123 |
| Other Gand A | 263,189 | 224,285 | 218,166 | 292,858 | 253,270 | -- |
| Reconciled Cost Of Revenue | 31,608 | 27,368 | 31,701 | 35,100 | 32,069 | -- |
| Salaries And Wages | -11,089 | 80,110 | 58,320 | -13,546 | 15,666 | -- |
| Total Expenses | 745,728 | 713,549 | 694,628 | 454,642 | 543,665 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 4.2M | 4.1M | 5.2M | 6.3M | 4.2M | -- |
| Cash Cash Equivalents And Short Term Investments | 4.2M | 4.1M | 5.2M | 6.3M | 4.2M | -- |
| Receivables | 1.4M | 2.5M | 1.8M | 445,665 | 2.0M | -- |
| Prepaid Assets | 229,230 | 299,484 | 388,849 | 655,006 | 344,337 | -- |
| Current Assets | 5.8M | 6.8M | 7.3M | 7.4M | 6.6M | -- |
| Gross PPE | 2.1M | 1.8M | 1.8M | 1.6M | 1.1M | -- |
| Accumulated Depreciation | -704,949 | -662,488 | -630,650 | -579,090 | -540,387 | -- |
| Net PPE | 1.4M | 1.2M | 1.2M | 983,181 | 531,598 | -- |
| Investments And Advances | 422,317 | 322,082 | 250,147 | 217,337 | 290,036 | -- |
| Long Term Equity Investment | 422,317 | 322,082 | 250,147 | 217,337 | 290,036 | -- |
| Total Non Current Assets | 2.0M | 1.7M | 1.7M | 1.4M | 1.0M | -- |
| Total Assets | 7.9M | 8.6M | 9.0M | 8.9M | 7.6M | -- |
| Accounts Payable | 667,340 | 417,544 | 715,380 | 523,020 | 416,320 | -- |
| Payables | 787,080 | 537,284 | 835,120 | 668,825 | 604,883 | -- |
| Payables And Accrued Expenses | 1.0M | 638,423 | 1.1M | 899,640 | 870,592 | -- |
| Current Accrued Expenses | 222,723 | 101,139 | 270,501 | 230,815 | 265,709 | -- |
| Current Liabilities | 5.2M | 5.6M | 5.4M | 5.5M | 3.8M | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 5.2M | 5.6M | 5.4M | 5.5M | 3.8M | -- |
| Common Stock | 54.2M | 54.2M | 54.2M | 54.2M | 54.2M | -- |
| Capital Stock | 54.2M | 54.2M | 54.2M | 54.2M | 54.2M | -- |
| Additional Paid In Capital | 9.1M | 9.1M | 9.1M | 9.1M | 9.1M | -- |
| Retained Earnings | -62.6M | -62.2M | -61.7M | -61.7M | -61.3M | -- |
| Gains Losses Not Affecting Retained Earnings | 300,647 | 143,109 | 238,238 | 149,471 | 110,860 | -- |
| Other Equity Adjustments | 300,647 | 143,109 | 238,238 | 149,471 | 110,860 | -- |
| Common Stock Equity | 2.7M | 3.0M | 3.6M | 3.4M | 3.8M | -- |
| Stockholders Equity | 2.7M | 3.0M | 3.6M | 3.4M | 3.8M | -- |
| Total Equity Gross Minority Interest | 2.7M | 3.0M | 3.6M | 3.4M | 3.8M | -- |
| Total Capitalization | 2.7M | 3.0M | 3.6M | 3.4M | 3.8M | -- |
| Net Tangible Assets | 2.7M | 3.0M | 3.6M | 3.4M | 3.8M | -- |
| Tangible Book Value | 2.7M | 3.0M | 3.6M | 3.4M | 3.8M | -- |
| Working Capital | 679,711 | 1.3M | 1.9M | 2.0M | 2.7M | -- |
| Invested Capital | 2.7M | 3.0M | 3.6M | 3.4M | 3.8M | -- |
| Share Issued | 105.6M | 105.1M | 105.1M | 105.1M | 105.1M | -- |
| Ordinary Shares Number | 105.6M | 105.1M | 105.1M | 105.1M | 105.1M | -- |
| Current Deferred Liabilities | 4.2M | 4.9M | 4.3M | 4.6M | 3.0M | -- |
| Duefrom Related Parties Current | 763,604 | 2.0M | 1.4M | 0.00 | 1.8M | -- |
| Income Tax Payable | 119,740 | 119,740 | 119,740 | 145,805 | 188,563 | -- |
| Investments In Other Ventures Under Equity Method | 422,317 | 322,082 | 250,147 | 217,337 | 290,036 | -- |
| Machinery Furniture Equipment | 138,364 | 129,313 | 127,276 | 125,372 | 122,427 | -- |
| Non Current Prepaid Assets | 207,737 | 233,830 | 241,644 | 239,962 | 216,886 | -- |
| Other Equity Interest | 1.7M | 1.7M | 1.7M | 1.7M | 1.6M | -- |
| Other Properties | 2.0M | 1.7M | 1.7M | 1.4M | 949,559 | -- |
| Other Receivables | 3,625 | 82,577 | 21,521 | 51,685 | 81,689 | -- |
| Taxes Receivable | 611,774 | 400,176 | 386,702 | 393,980 | 161,710 | -- |
| Total Tax Payable | 119,740 | 119,740 | 119,740 | 145,805 | 188,563 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 302,287 | -1.0M | -1.6M | 1.9M | -152,656 | -- |
| Cash Flow From Continuing Operating Activities | 304,310 | -1.0M | -1.6M | 1.9M | -152,656 | -- |
| Depreciation And Amortization | 31,608 | 27,368 | 31,701 | 35,100 | 32,069 | -- |
| Depreciation Amortization Depletion | 31,608 | 27,368 | 31,701 | 35,100 | 32,069 | -- |
| Stock Based Compensation | -11,089 | 80,110 | 58,320 | -13,546 | 15,666 | -- |
| Change In Working Capital | 775,587 | -484,632 | -1.1M | 2.9M | 139,470 | -- |
| Changes In Account Receivables | -132,646 | -74,529 | 37,441 | -202,267 | 50,236 | -- |
| Change In Receivables | 1.1M | -708,416 | -1.3M | 1.6M | -1.4M | -- |
| Change In Payables And Accrued Expense | 371,380 | -467,199 | 205,982 | 29,048 | -303,641 | -- |
| Change In Other Working Capital | -780,005 | 601,618 | -226,315 | 1.6M | 1.7M | -- |
| Other Non Cash Items | -2,023 | 2,030 | -592,493 | -- | -- | -- |
| Capital Expenditure | -269,911 | -29,745 | -221,805 | -505,004 | -36,420 | -- |
| Purchase Of PPE | -6,205 | -713.00 | -56,369 | -84,365 | -29,809 | -- |
| Net PPE Purchase And Sale | 19,887 | 5,420 | -56,369 | -84,365 | -29,809 | -- |
| Investing Cash Flow | -209,602 | -23,613 | 378,924 | 19,834 | -36,420 | -- |
| Cash Flow From Continuing Investing Activities | -241,828 | -23,612 | 378,923 | 19,834 | -36,420 | -- |
| Issuance Of Capital Stock | 0.00 | 0.00 | 0.00 | -- | 29,310 | 33,354 |
| Repurchase Of Capital Stock | -- | -- | -- | 944.00 | -14,771 | -- |
| Net Common Stock Issuance | -944.00 | 0.00 | 0.00 | -61,720 | 14,539 | -- |
| Common Stock Payments | -- | -- | -- | 944.00 | -14,771 | -- |
| Financing Cash Flow | -944.00 | 0.00 | 0.00 | 944.00 | 14,539 | -- |
| Cash Flow From Continuing Financing Activities | -944.00 | 0.00 | 0.00 | 943.00 | 14,539 | -- |
| Effect Of Exchange Rate Changes | 97,554 | -78,110 | 12,106 | 190,053 | 35,672 | -- |
| Changes In Cash | 91,740 | -1.0M | -1.2M | 1.9M | -174,536 | -- |
| Beginning Cash Position | 4.1M | 5.2M | 6.3M | 4.2M | 4.4M | -- |
| End Cash Position | 4.2M | 4.1M | 5.2M | 6.3M | 4.2M | -- |
| Free Cash Flow | 32,376 | -1.0M | -1.8M | 1.4M | -189,076 | -- |
| Capital Expenditure Reported | -263,706 | -29,032 | -165,436 | -420,639 | -6,611 | -- |
| Change In Prepaid Assets | 70,254 | 89,365 | 266,157 | -310,669 | 130,620 | -- |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | -- | 29,310 | 33,354 |
| Depreciation | 31,608 | 27,368 | 31,701 | 35,100 | 32,069 | -- |
| Gain Loss On Sale Of PPE | -63.00 | -4,315 | 305.00 | -- | 0.00 | 0.00 |
| Net Foreign Currency Exchange Gain Loss | 20,846 | -19,788 | 77,130 | -171,074 | 132,434 | -- |
| Net Income From Continuing Operations | -412,344 | -540,376 | 451.00 | -393,038 | -356,774 | -- |
| Net Other Investing Changes | 34,217 | -1.00 | 600,729 | -- | -- | -- |
| Operating Gains Losses | 20,783 | -24,103 | 77,435 | -- | -- | -30,497 |
| Proceeds From Stock Option Exercised | -- | -- | -- | -1.00 | -- | -- |
| Sale Of PPE | 26,092 | -- | -- | -- | -- | -- |
| Unrealized Gain Loss On Investment Securities | -100,235 | -71,935 | -32,810 | 72,699 | -115,521 | -- |